This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.
|Translated title of the contribution||CCNU in the chemotherapy of tumours of the central nervous system (author's transl)|
|Number of pages||5|
|Journal||Rivista di Patologia Nervosa e Mentale|
|Publication status||Published - May 1977|
ASJC Scopus subject areas